Table 1.
Description of the Sample (N= 247)
| Gender | N | % |
|---|---|---|
| Male | 124 | 50.2 |
| Female | 123 | 49.8 |
| Ethnicity | ||
| Caucasian | 206 | 83.4 |
| Hispanic | 14 | 5.7 |
| Asian/Pacific Islander | 7 | 2.8 |
| African-American | 6 | 2.4 |
| Other | 11 | 4.5 |
| Missing | 3 | 1.2 |
| Age at Enrollment | ||
| 18–21 | 55 | 22.3 |
| 22–26 | 45 | 18.2 |
| 27–31 | 41 | 16.6 |
| 32–36 | 40 | 16.2 |
| 37–40 | 66 | 26.7 |
| Age at DX | ||
| 0–5 | 20 | 8.1 |
| 6–11 | 23 | 9.3 |
| 12–17 | 68 | 27.5 |
| 18–23 | 37 | 15 |
| 24–30 | 49 | 19.8 |
| 31+ | 50 | 20.2 |
| Cancer-Related Treatment | ||
| Surgery | 140 | 56.7 |
| Radiation | 152 | 61.5 |
| Chemotherapy | 214 | 86.6 |
| Bone marrow/stem cell transplant | 50 | 20.2 |
| Years Since Treatment | ||
| 2–4 | 99 | 40.1 |
| 5–9 | 91 | 36.8 |
| 10–15 | 27 | 10.9 |
| 15+ | 28 | 11.3 |
| missing | 2 | 0.8 |
| Cancer Diagnosis | ||
| Hodgkin’s Lymphoma | 50 | 20.2 |
| Leukemia | 49 | 19.8 |
| Brain tumor | 30 | 12.1 |
| Non-Hodgkin’s Lymphoma | 30 | 12.1 |
| Testicular | 27 | 10.9 |
| Breast | 24 | 9.7 |
| Sarcomas | 20 | 8.1 |
| Other | 17 | 6.9 |
| Distress Thermometer | N | % |
| 0 | 49 | 19.8 |
| 1 | 37 | 15 |
| 2 | 39 | 15.8 |
| 3 | 33 | 13.4 |
| 4 | 15 | 6.1 |
| 5 | 20 | 8.1 |
| 6 | 20 | 8.1 |
| 7 | 19 | 7.7 |
| 8 | 13 | 5.3 |
| 9 | 0 | 0 |
| 10 | 2 | 0.8 |
| SCID Criteria | N | % |
| SCID Diagnosis | 44 | 17.8 |
| Significant SCID Symptoms no Diagnosis | 20 | 8.1 |
| No Significant SCID Symptoms | 183 | 74.1 |